| Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials JC Nelson, GI Papakostas American Journal of Psychiatry 166 (9), 980-991, 2009 | 661 | 2009 |
| Treatment-resistant depression D Souery, GI Papakostas, MH Trivedi Journal of Clinical Psychiatry 67, 16, 2006 | 507 | 2006 |
| Quality of life assessments in major depressive disorder: a review of the literature GI Papakostas, T Petersen, Y Mahal, D Mischoulon, AA Nierenberg, ... General hospital psychiatry 26 (1), 13-17, 2004 | 460 | 2004 |
| Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD GI Papakostas, M Fava European Neuropsychopharmacology 19 (1), 34-40, 2009 | 423 | 2009 |
| Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major … GI Papakostas, ME Thase, M Fava, JC Nelson, RC Shelton Biological psychiatry 62 (11), 1217-1227, 2007 | 403 | 2007 |
| Adjunctive nutraceuticals for depression: a systematic review and meta-analyses J Sarris, J Murphy, D Mischoulon, GI Papakostas, M Fava, M Berk, CH Ng American Journal of Psychiatry 173 (6), 575-587, 2016 | 369 | 2016 |
| Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation RS McIntyre, JD Rosenblat, CB Nemeroff, G Sanacora, JW Murrough, ... American Journal of Psychiatry 178 (5), 383-399, 2021 | 368 | 2021 |
| A detailed examination of cytokine abnormalities in Major Depressive Disorder NM Simon, K McNamara, CW Chow, RS Maser, GI Papakostas, ... European Neuropsychopharmacology 18 (3), 230-233, 2008 | 364 | 2008 |
| Treatment of SSRI-resistant depression: a meta-analysis comparing within-versus across-class switches GI Papakostas, M Fava, ME Thase Biological psychiatry 63 (7), 699-704, 2008 | 351 | 2008 |
| l-Methylfolate as Adjunctive Therapy for SSRI-Resistant Major Depression: Results of Two Randomized, Double-Blind, Parallel-Sequential Trials GI Papakostas, RC Shelton, JM Zajecka, B Etemad, K Rickels, A Clain, ... American Journal of Psychiatry 169 (12), 1267-1274, 2012 | 341 | 2012 |
| Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD) M Fava, MP Freeman, M Flynn, H Judge, BB Hoeppner, C Cusin, ... Molecular psychiatry 25 (7), 1592-1603, 2020 | 329 | 2020 |
| S-Adenosyl Methionine (SAMe) Augmentation of Serotonin Reuptake Inhibitors for Antidepressant Nonresponders With Major Depressive Disorder: A Double-Blind … GI Papakostas, D Mischoulon, I Shyu, JE Alpert, M Fava American Journal of Psychiatry 167 (8), 942-948, 2010 | 328 | 2010 |
| Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis. GI Papakostas, RC Shelton, J Smith, M Fava Journal of Clinical Psychiatry 68 (6), 826-831, 2007 | 324 | 2007 |
| Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials E Tedeschini, Y Levkovitz, N Iovieno, VE Ameral, JC Nelson, ... The Journal of clinical psychiatry 72 (12), 5967, 2011 | 305 | 2011 |
| A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment M Fava, LM Graves, F Benazzi, MJ Scalia, DV Iosifescu, JE Alpert, ... Journal of Clinical Psychiatry 67 (11), 1754-1759, 2006 | 279 | 2006 |
| Relationship between sleep disturbance and depression, anxiety, and functioning in college students M Nyer, A Farabaugh, K Fehling, D Soskin, D Holt, GI Papakostas, ... Depression and anxiety 30 (9), 873-880, 2013 | 263 | 2013 |
| Effects of smartphone use with and without blue light at night in healthy adults: A randomized, double-blind, cross-over, placebo-controlled comparison JY Heo, K Kim, M Fava, D Mischoulon, GI Papakostas, MJ Kim, DJ Kim, ... Journal of psychiatric research 87, 61-70, 2017 | 236 | 2017 |
| Dopaminergic-based pharmacotherapies for depression GI Papakostas European Neuropsychopharmacology 16 (6), 391-402, 2006 | 229 | 2006 |
| Tolerability of modern antidepressants GI Papakostas J Clin Psychiatry 69 (Suppl E1), 8-13, 2008 | 224 | 2008 |
| Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder GI Papakostas, TJ Petersen, AA Nierenberg, JL Murakami, JE Alpert, ... Journal of Clinical Psychiatry 65 (2), 217-221, 2004 | 222 | 2004 |
